DGAP-Adhoc: DR. MARIOLA SÖHNGEN WILL LEAVE MANAGEMENT BOARD OF PAION AG AS OF 31 OCTOBER 2015 TO PURSUE A NEW CHALLENGE


PAION AG  / Key word(s): Change of Personnel

07.07.2015 20:23

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

DR. MARIOLA SÖHNGEN WILL LEAVE MANAGEMENT BOARD OF PAION AG AS OF 31
OCTOBER 2015 TO PURSUE A NEW CHALLENGE

 
  - Dr. Mariola Söhngen, Chief Medical Officer of PAION AG, will resign
    from her office as management board member as of 31 October 2015

  - Supervisory Board extends appointment of Dr. Wolfgang Söhngen as CEO of
    PAION AG until end of December 2018

Aachen (Germany), 07 July 2015 - PAION AG, a Specialy Pharma Company (ISIN
DE000A0B65S3; Frankfurt Stock Exchange Prime Standard: PA8) today announces
that Dr. Mariola Söhngen, Chief Medical Officer ("CMO") of the Company, has
informed the Chairman of the Supervisory Board that she wants to leave the
Management Board of the Company‎ prior to the end of her current
appointment until 31 December 2016, to pursue a new management challenge.
Today the Supervisory Board has basically agreed with Mrs. Söhngen that she
will resign from office as of 31 October 2015. The details of the
termination agreement will be agreed between the Supervisory Board and Mrs.
Söhngen. Mrs. Söhngen will continue to provide her expertise as a
consultant on request after her departure.

In connection with the step-down of Mrs. Söhngen, the Supervisory Board
decided to extend the appointment and contract of Dr. Wolfgang Söhngen as
CEO of the Company by another year until end of 2018. In the interim, Mr.
Söhngen will take over certain of Mrs. Söhngen's functions until the
appointment of a new CMO and thus will ensure a smooth transition.

###

Contact
Ralf Penner
Director Investor Relations / Public Relations
PAION AG
Martinstrasse 10-12
52062 Aachen - Germany
Phone: +49 241 4453-152
E-mail: r.penner@paion.com
www.paion.com 

Disclaimer:
This release contains certain forward-looking statements concerning the
future business of PAION AG. These forward-looking statements contained
herein are based on the current expectations, estimates and projections of
PAION AG's management as of the date of this release. They are subject to a
number of assumptions and involve known and unknown risks, uncertainties
and other factors. Should actual conditions differ from the Company's
assumptions, actual results and actions may differ materially from any
future results and developments expressed or implied by such
forward-looking statements. Considering the risks, uncertainties and other
factors involved, recipients should not rely unreasonably upon these
forward-looking statements. PAION AG has no obligation to periodically
update any such forward-looking statements to reflect future events or
developments.


07.07.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      PAION AG
              Martinstr. 10-12
              52062 Aachen
              Germany
Phone:        +49 (0)241-4453-0
Fax:          +49 (0)241-4453-100
E-mail:       info@paion.com
Internet:     www.paion.com
ISIN:         DE000A0B65S3
WKN:          A0B65S
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated
              Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
              Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------